SAR231893-LPS15497- "Dupilumab Effect on Sleep in AD Patients"

Summary

Primary Objective: To evaluate the effect of dupilumab on sleep quality in adult participants with moderate to severe atopic dermatitis (AD). Secondary Objectives: To evaluate the effect of dupilumab on objective and subjective quantitative sleep parameters, AD related outcomes, and daytime consequences of sleep deprivation. To continue to assess the safety and tolerability throughout the study.

Timeline

Start

2019-08-22

Primary completion

2021-10-06

Completion

2021-10-06

Drugs

Indications